Short Interest in Carmell Co. (NASDAQ:CTCX) Expands By 688.2%

Carmell Co. (NASDAQ:CTCX) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 827,600 shares, a growth of 688.2% from the December 15th total of 105,000 shares. Based on an average trading volume of 10,930,000 shares, the short-interest ratio is presently 0.1 days. Currently, 6.1% of the company’s stock are sold short.

Carmell Trading Down 1.0 %

Shares of CTCX traded down $0.01 on Wednesday, reaching $0.61. The company’s stock had a trading volume of 529,198 shares, compared to its average volume of 37,132,742. Carmell has a twelve month low of $0.20 and a twelve month high of $4.00. The firm has a fifty day moving average of $0.32 and a 200-day moving average of $0.61.

Institutional Investors Weigh In On Carmell

An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC bought a new position in Carmell Co. (NASDAQ:CTCX) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned about 0.22% of Carmell at the end of the most recent reporting period. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Carmell Company Profile

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.